|
⚲
|
| Keyboard |
| Smith Susan Laura
✚
|
|
|---|---|
| CIK # | 0001901039 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001901039] | |
| 4 | [0001901039] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Smith Susan Laura | |
| Y-mAbs Therapeutics Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Y-mAbs Therapeutics Inc YMAB
Common Stock
|
2024-03-05 | Sell | 1,682 | $16.55 | 27,837 |
|
Y-mAbs Therapeutics Inc YMAB
Employee Stock Option (right to buy) · derivative
|
2024-01-18 | Grant | 35,700 | $0.00 | |
|
Y-mAbs Therapeutics Inc YMAB
Common Stock
|
2024-01-18 | Grant | 17,800 | $0.00 | |
|
Y-mAbs Therapeutics Inc YMAB
Employee Stock Option (right to buy) · derivative
|
2023-01-26 | Grant | 32,000 | $0.00 | |
|
Y-mAbs Therapeutics Inc YMAB
Employee Stock Option (right to buy) · derivative
|
2023-01-17 | Grant | 35,700 | $0.00 | |
|
Y-mAbs Therapeutics Inc YMAB
Common Stock
|
2023-01-17 | Grant | 17,800 | $0.00 | |
|
Y-mAbs Therapeutics Inc YMAB
Employee Stock Option (right to buy) · derivative
|
2022-04-26 | Grant | 20,000 | $0.00 | |
|
Y-mAbs Therapeutics Inc YMAB
Employee Stock Option (right to buy) · derivative
|
2021-12-14 | Grant | 64,000 | $0.00 |